Cardiff Oncology (CRDF) Non-Current Debt (2013 - 2020)

Cardiff Oncology has reported Non-Current Debt for 6 years, with the latest figure at $234270.0 in Q2 2020.

• Quarterly Non-Current Debt changed N/A year-over-year to $234270.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $234270.0 (changed N/A YoY) and the FY2016 annual result came in at $14.2 million, up 26.05% from the prior year.
• Non-Current Debt declined to $234270.0 in Q2 2020 per CRDF's latest filing, from $12.7 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $15.6 million in Q3 2016 and troughed at $234270.0 in Q2 2020.
• A 3-year average of $10.4 million and a median of $11.5 million in 2016 frame the typical range for Non-Current Debt.
• The widest YoY moves for Non-Current Debt: up 35.39% in 2016, down 29.89% in 2016.
• Over 3 years, Non-Current Debt stood at $14.2 million in 2016, then fell by 10.42% to $12.7 million in 2017, then plunged by 98.16% to $234270.0 in 2020.
• According to Business Quant data, Non-Current Debt over the past three periods registered $234270.0, $12.7 million, and $14.2 million for Q2 2020, Q1 2017, and Q4 2016 respectively.